TRAM Snapshot of App at Pub for Oppostn

ROCKETSCRIPT

BIONEER CORPORATION

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 88018527 FILING DATE 06/28/2018
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY BAKER, JORDAN A
L.O. ASSIGNED N60-NOT FOUND

PUB INFORMATION

RUN DATE 09/04/2019
PUB DATE N/A
STATUS 680-APPROVED FOR PUBLICATION
STATUS DATE 09/03/2019
LITERAL MARK ELEMENT ROCKETSCRIPT

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) NO 1 (b) NO
44D YES 44D NO 44D NO
44E NO 44E YES 44E YES
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT ROCKETSCRIPT
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME BIONEER CORPORATION
ADDRESS 8-11, Munpyeongseo-ro, Daedeok-gu
Daejeon, 34302
ENTITY 03-CORPORATION
CITIZENSHIP Republic of Korea

GOODS AND SERVICES

INTERNATIONAL CLASS 001
          DESCRIPTION TEXT biological enzymes for non-medical use; compositions for use in cDNA synthesis for research purposes; kits for use in cDNA synthesis for research purposes comprised of reagents, buffers, reverse transcriptase, oligomer; compositions for use in nucleic acid fluorescence staining for research purposes; kits for use in nucleic acid fluorescence staining for research purposes consisting of reagents, buffers, staining reagents; compositions for use in DNA sequence analysis for research purposes; kits for use in DNA sequence analysis for research purposes consisting of reagents, buffers, DNA polymerase; nucleic acid polymerase for research purposes; compositions for use in nucleic acid amplification for research purposes; kits for use in nucleic acid amplification for research purposes consisting of reagents, buffers, nucleic acid polymerase; chemical reagents for research purposes; compositions for use in polymerase chain reaction for research purposes; compositions for use in reverse transcription for research purposes
INTERNATIONAL CLASS 005
          DESCRIPTION TEXT biological enzymes for medical use; kits for use in cDNA synthesis for medical purposes comprised of reagents, buffers, reverse transcriptase, oligomer; compositions for use in nucleic acid fluorescence staining for medical purposes; kits for use in nucleic acid fluorescence staining for medical purposes consisting of reagents, buffers, staining reagents; compositions for use in DNA sequence analysis for medical purposes; kits for use in DNA sequence analysis for medical purposes consisting of reagents, buffers, DNA polymerase; nucleic acid polymerase for medical purposes; compositions for use in nucleic acid amplification for medical purposes; kits for use in nucleic acid amplification for medical purposes consisting of reagents, buffers, nucleic acid polymerase; chemical reagents for medical purposes; compositions for use in nucleic acid amplification for medical purposes; compositions for use in reverse transcription for medical purposes

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 001 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
PSEUDO MARK ROCKET SCRIPT

FOREIGN INFORMATION

PRIORITY CLAIMED SEC. 44(D) ON Republic of Korea
APPLICATION NO. 402018084005
APPLICATION FILING DATE 06/21/2018
FOREIGN REG NO. 40-1507582
FOREIGN REG DATE 08/07/2019
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION 06/21/2028
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
09/03/2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER 014
08/30/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 013
08/30/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 012
08/29/2019 ALIE A ASSIGNED TO LIE 011
08/23/2019 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED 010
04/24/2019 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED 009
04/24/2019 GNSI S INQUIRY TO SUSPENSION E-MAILED 008
04/24/2019 CNSI R SUSPENSION INQUIRY WRITTEN 007
10/22/2018 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED 006
10/22/2018 GNSL F LETTER OF SUSPENSION E-MAILED 005
10/22/2018 CNSL R SUSPENSION LETTER WRITTEN 004
10/19/2018 DOCK D ASSIGNED TO EXAMINER 003
07/03/2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
07/02/2018 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Steven J. Hultquist
CORRESPONDENCE ADDRESS Steven J. Hultquist
HULTQUIST, PLLC
PO BOX 14329
RESEARCH TRIANGLE PARK NC 27709
DOMESTIC REPRESENTATIVE NONE

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed